Coalition for Patient Rights (CPR) Urges Immediate Medical Cannabis Law Reform in Nevada with Broad Support from Integrative Healthcare

September 25, 2024 5:30 PM

Compassion Center celebrates and champions the Coalition for Patient Rights (CPR) in leading the charge for urgent reforms in Nevada's medical cannabis laws, advocating for reduced fees, patient cultivation rights, and an overhaul of outdated DUID laws. Join CPR in protecting patient access, promoting fair legislation, and ensuring the safe use of natural, organic cannabis for qualifying patients across the state. Get involved by attending...

Read more

Prevail Partners and Prevail InfoWorks Enter Into Strategic Investment and Clinical Alliance With Kairos Pharma, Ltd.

September 25, 2024 1:30 PM

PHILADELPHIA, PA / ACCESSWIRE / September 25, 2024 / Prevail Partners LLC ("Prevail Partners") and Prevail InfoWorks Inc. ("Prevail InfoWorks") announce that they have entered into a strategic relationship with Kairos Pharma, Ltd. ("Kairos"), a clinical stage biopharmaceutical company located in Los Angeles, California, and the developer of innovative therapeutics that aim to reverse cancer resistance against standard of care therapeutics. Under...

Read more

Gruber Plastic Surgery Dispels Misconceptions on Awake Surgeries

September 25, 2024 11:45 AM

Dr. Meegan Gruber looks at myths vs. facts on safer, less invasive procedures.TAMPA, FL / ACCESSWIRE / September 25, 2024 / Awake surgery is becoming increasingly popular as patients seek safer, less invasive options for cosmetic procedures. However, several myths may deter some patients from considering this innovative approach to cosmetic procedures. To separate fact from fiction, Tampa plastic surgeon Dr. Meegan Gruber, a board-certified...

Read more

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

September 25, 2024 10:45 AM

Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced that management will present at the 3rd Annual ROTH Healthcare Opportunities Conference to be held at the Metropolitan Club in New York, NY.Date: October 9, 2024Time of Presentation: 12:30 - 1:10 PM ETFormat: Live Presentation1x1 Meetings: Please contact your Roth representativeAbout Biofrontera...

Read more

Quasar Medical Acquires Ridgeback Technologies

September 25, 2024 10:00 AM

Quasar Medical Is Expanding Its Capabilities By Adding Balloon CathetersSAINT PAUL, MN / ACCESSWIRE / September 25, 2024 / Quasar Medical, a global leader in manufacturing complex minimally invasive medical devices, announces the acquisition of Ridgeback Technologies, an innovator in the design, development, and manufacture of cutting-edge catheter balloons. Known for its expertise in rapidly designing and producing a wide range of specialized...

Read more

Championing HIV Services for LGBTQ+ Youth

September 25, 2024 9:55 AM

NORTHAMPTON, MA / ACCESSWIRE / September 25, 2024 / Gilead Sciences As a young gay professional, Terrell Parker spent several years working at the National Minority AIDS Council in Washington, D.C. during his 20s, advocating to help end the HIV epidemic and reduce stigma.When Terrell moved back home to Indianapolis, he ran into an issue with his insurance that left him unable to get his prescription for pre-exposure prophylaxis, or PrEP - a...

Read more

Savista to Share Bold Predictions for the Future of Healthcare at MGMA Leaders Conference

September 25, 2024 9:30 AM

Savista, a leading healthcare revenue cycle management services company, is attending the Medical Group Management Association (MGMA) Leaders Conference from Oct. 6-9, 2024 at the Colorado Convention Center in Denver.Savista's Chief Strategy Officer Laxmi Patel will speak about major transformations in the healthcare industry at a sponsored session taking place on Oct. 8 from 8-9 a.m. local time. During the session, Laxmi will discuss the...

Read more

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

September 25, 2024 9:25 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that sales of its proprietary brands, including Sky Premium Life, on Amazon in the United Kingdom have surged by 160%,...

Read more

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

September 25, 2024 9:20 AM

TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that Jason Sawyer, Head of Finance and Mergers and Acquisitions, will present at the ArcStone-Kingswood Growth Summit held on September 26, 2024,...

Read more

GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

September 25, 2024 9:00 AM

ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating the safety and efficacy of its investigational drug, GN-037 topical cream, in treating mild to moderate plaque psoriasis. The findings were presented at Amsterdam's European Academy of Dermatology and Venereology (EADV) 2024 Congress.GEN...

Read more

Incredable(TM) (Formerly Ready Doc(R)) Launches New Provider App and Announces Attendance at NAMMS Conference

September 25, 2024 9:00 AM

As part of its recent rebrand, Incredable™ unveils a mobile app designed to streamline credentialing processes, reduce manual work, and increase provider efficiency. The company will showcase its new platform and app at the upcoming NAMMS Conference in Denver.AUSTIN, TX/ ACCESSWIRE / September 25, 2024 / Incredable™, backed by parent company Intiva Health and a leading credentialing and compliance solutions provider, is excited to announce the...

Read more

Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa

September 25, 2024 8:50 AM

The Africa Centres for Disease Control and Prevention (Africa CDC) and IAVI, a nonprofit scientific research organization, have signed a Memorandum of Understanding (MoU) to enhance the continent's disease-fighting capacity, pandemic readiness, and supply resilience by expanding capabilities for locally driven research, development, manufacturing, and supply of priority vaccines and antibodies and to strengthen Africa CDC-led initiatives with...

Read more

Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

September 25, 2024 8:30 AM

SAN FRANCISCO, CA / ACCESSWIRE / September 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference , taking place virtually on Tuesday, October 1, 2024.Company WebcastThe webcasted presentation will take place at 1:15pm Eastern on Tuesday,...

Read more

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

September 25, 2024 8:00 AM

Next step will be receiving approval from Taiwan Food and Drug Administration (TFDA)SAN DIEGO, CA / ACCESSWIRE / September 25, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today announced it has received Institutional Review Board (IRB) approval from the National Taiwan University...

Read more

NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split

September 25, 2024 8:00 AM

NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that a reverse share split of the Company's issued and outstanding common shares, par value CHF 0.02 per share (the "Common Shares"), at a ratio of 1-for-40 is expected to...

Read more

Ondine Biomedical Inc. Announces Collaboration advances Steriwave for ICU Market

September 25, 2024 2:00 AM

Ondine Biomedical Inc. (LON:OBI), the Canadian life sciences company at the forefront of light-activated antimicrobial treatments, is pleased to announce a research collaboration with the Royal Columbian Hospital (RCH) Foundation's Advancing Innovation in Medicine (AIM) division.This research collaboration, in support of Steriwave ® use in the intensive care unit (ICU), is investigating Steriwave's impact on infection prevention and patient...

Read more

Cantargia Presents New Results at EADV 2024 Highlighting the Potential of CAN10 Treatment in Dermatology

September 25, 2024 1:20 AM

LUND, SE / ACCESSWIRE / September 25, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today presented data from preclinical experiments showing the high potential of the IL1RAP targeting antibody CAN10 in treatment of dermatological diseases. The results show overexpression of IL1RAP in a number cell types in hidradenitis suppurativa (HS) and psoriasis skin lesions. The treatment effect of CAN10 in models of skin...

Read more

IRLAB Presents at the International Congress of Parkinson's Disease and Movement Disorders(R)(MDS) 2024

September 25, 2024 1:20 AM

GOTHENBURG, SE / ACCESSWIRE / September 25, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 25, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, today announced that the company will present a poster at this year's edition of the International Congress of Parkinson's Disease and Movement Disorders (MDS), September 27 - October...

Read more

UNOS Applauds House Action to Prohibit Discrimination in Organ Transplants

September 25, 2024 12:25 AM

Today, Maureen McBride, Ph.D., the CEO of the United Network for Organ Sharing (UNOS), issued the following statement after the U.S. House of Representatives passed the Charlotte Woodward Organ Transplant Discrimination Prevention Act. This legislation prohibits discrimination in organ transplantation against individuals with physical or intellectual disabilities. UNOS applauds the House's passage of the Charlotte Woodward Organ Transplant...

Read more

Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options

September 24, 2024 5:00 PM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed a Non-Brokered Private Placement ("NBPP")...

Read more